Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIIB Anal Canal Cancer”

27 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 27 results

Testing effectiveness (Phase 2)Ended earlyNCT00955240
What this trial is testing

Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer

Who this might be right for
Anal Cancer
UNICANCER 16
Not applicableStudy completedNCT05130073
What this trial is testing

4-Point Therapy Response Score With PET/CT for Anal Squamous Cell Cancer

Who this might be right for
Anal Squamous Cell CarcinomaStage 0 Anal Cancer AJCC v8Stage I Anal Cancer AJCC v8+7 more
M.D. Anderson Cancer Center 41
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Post-approval studies (Phase 4)UnknownNCT00274885
What this trial is testing

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Who this might be right for
Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)Study completedNCT00093379
What this trial is testing

Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer

Who this might be right for
Anal Cancer
M.D. Anderson Cancer Center 20
Testing effectiveness (Phase 2)Ended earlyNCT01843452
What this trial is testing

Phase II Study of Concomitant Intensity-modulated Radiotherapy Combined to Capecitabine, Mitomycin and Panitumumab in Patients With Stage II-IIIB Squamous-cell Carcinoma of the Anal Canal

Who this might be right for
Carcinoma of Anal Canal
Centre Hospitalier Universitaire Vaudois 8
Not applicableStudy completedNCT00253383
What this trial is testing

Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients

Who this might be right for
Cancer
Dartmouth-Hitchcock Medical Center 329
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT00003704
What this trial is testing

Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer

Who this might be right for
Cancer
Alliance for Clinical Trials in Oncology 51
Testing effectiveness (Phase 2)Study completedNCT00423293
What this trial is testing

Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer

Who this might be right for
Anal Cancer
Radiation Therapy Oncology Group 63
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Testing effectiveness (Phase 2)Study completedNCT00316888
What this trial is testing

Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer

Who this might be right for
Anal Cancer
ECOG-ACRIN Cancer Research Group 63
Large-scale testing (Phase 3)Study completedNCT00025090
What this trial is testing

Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer

Who this might be right for
Anal Cancer
University College London (UCL) Cancer Institute 600
Early research (Phase 1)Study completedNCT00003867
What this trial is testing

Irinotecan and Capecitabine in Treating Patients With Solid Tumors

Who this might be right for
Cancer
Montefiore Medical Center 30
Testing effectiveness (Phase 2)UnknownNCT02560298
What this trial is testing

Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal Cancer

Who this might be right for
Anal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaAnal Squamous Cell Carcinoma+4 more
ECOG-ACRIN Cancer Research Group 91
Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Large-scale testing (Phase 3)Study completedNCT00075868
What this trial is testing

Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer

Who this might be right for
Anal CancerColorectal CancerDrug/Agent Toxicity by Tissue/Organ+1 more
Radiation Therapy Oncology Group 233
Testing effectiveness (Phase 2)Study completedNCT03690921
What this trial is testing

Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial

Who this might be right for
Anal Canal Squamous Cell CarcinomaStage I Anal Cancer AJCC v8Stage II Anal Cancer AJCC v8+6 more
M.D. Anderson Cancer Center 8
Load More Results